Citigroup »

Inhibrx shares owned by Citigroup

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 45k 38.00
2023-09-30 $905k 49k 18.37
2023-03-31 $2.3M 124k 18.87
2022-12-31 $2.1M 87k 24.64
2022-09-30 $2.2M 122k 17.95
2021-12-31 $1.6M 37k 43.66
2021-03-31 $13k 637 20.41
2020-12-31 $54k 1.6k 33.09